Physician

Robert L Cody, M.D.

According to 2025 Medicare claims, Robert Cody, M.D. (NPI: 1295721215) practices hematology/oncology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Hamilton, OH. This provider's primary affiliated billing organization is CHRIST HOSPITAL MEDICAL SPECIALISTS II, LLC (NPI: 1891065256; TIN: 452681845) and primary practice location at 45227-2173.

Cody's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 620 traditional Medicare patients, billed 106,149 HCPCS/CPT codes, and received $1,831,547 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 882 prescription claims across 235 beneficiaries totaling $1,679,361 in drug costs, led by Ibrance (Palbociclib). 2023 DME data shows 12 claims. Open Payments data shows 1 records totaling $65. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $682,878 to $1,679,361. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	509	91,829	$1,614,875
2016	578	104,814	$2,021,713
2017	602	103,907	$1,918,876
2018	621	134,100	$2,484,855
2019	631	122,635	$2,545,192
2020	560	151,089	$2,594,475
2021	599	160,736	$2,349,554
2022	581	91,220	$1,533,053
2023	632	83,889	$1,557,589
2024	620	106,149	$1,831,547

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	289	1,435	$682,878
2016	307	1,499	$1,161,297
2017	325	1,600	$841,643
2018	341	1,503	$971,408
2019	369	1,786	$1,638,953
2020	361	1,762	$1,586,773
2021	345	1,736	$3,110,630
2022	247	916	$2,033,481
2023	207	752	$1,399,620
2024	235	882	$1,679,361

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	77	$5,355
2016	30	53	$7,196
2017	16	21	$2,393
2018	14	17	$1,817
2019	13	16	$1,724
2020	N/R	N/R	N/R
2021	N/R	167	$90,981
2022	N/R	N/R	N/R
2023	N/R	12	$587
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	100	221	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	376	667	$80
J0897	Injection, denosumab, 1 mg	82	11,820	$21
96372	Injection of drug or substance under skin or into muscle	121	326	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	373	1,002	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	33	924	$501,173
Lapatinib	Lapatinib Ditosylate	12	360	$30,367
Eliquis	Apixaban	23	780	$15,086
Xarelto	Rivaroxaban	19	810	$14,814
Anastrozole	Anastrozole	151	10,152	$2,478

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$65	Incyte Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert L. Cody, M.D.?

Tedicare shows public-source Medicare data for Robert L. Cody, M.D. (NPI 1295721215), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert L. Cody, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert L. Cody, M.D.?

Robert L. Cody, M.D. is linked to CHRIST HOSPITAL MEDICAL SPECIALISTS II, LLC (billing NPI 1891065256) in the available physician profile data.

Does Robert L. Cody, M.D. have Open Payments data?

Robert L. Cody, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.